Most laboratories calculate LDL rather than measure it, and some print no range at all. How NICE and European goals differ by risk, what usually raises LDL, and what a doctor checks before deciding anything.
An LDL cholesterol of 2.6 mmol/L can sit inside the range one NHS laboratory prints and above the goal English guidance sets for people who already have cardiovascular disease and take lipid-lowering treatment. Both are correct. They answer different questions, and knowing which question your report answers is most of the work of reading it.
This material is for information only. It is not a diagnosis and does not replace a consultation with a doctor.
What does the LDL number actually measure?
LDL is the cholesterol carried in low-density lipoprotein particles. In most laboratories it is not measured directly. NICE guidance on cardiovascular risk (NG238, 2023) describes the full lipid profile this way: the laboratory measures total cholesterol, HDL cholesterol and triglycerides, then calculates non-HDL cholesterol and LDL cholesterol.
The calculation is the reason LDL is sometimes missing from a report. NICE notes that LDL may not be reported when triglycerides are above 4.5 or 9 mmol/L, depending on the formula the laboratory uses. One NHS laboratory, University Hospitals of North Midlands, uses the older Friedewald calculation and says it is not appropriate above 4.5 mmol/L. University Hospitals Sussex uses a newer equation and calls its result unreliable above 9 mmol/L and not valid above 20 mmol/L.
A fasting sample is not required by NICE, and the European guideline (ESC/EAS, 2019) says the practical advantages of non-fasting samples outweigh the possible imprecision in some patients. Some laboratories still ask for fasting, so the instruction on your request form is the one to follow.
Where do the numbers on your report come from?
Laboratories handle LDL in three different ways:
A printed range. University Hospitals of North Midlands gives 1.5–4 mmol/L for all ages and both sexes.
A range with a warning. University Hospitals Sussex prints below 3.0 mmol/L and adds that risk increases with LDL cholesterol above 2 mmol/L.
No range at all. Gloucestershire Hospitals does not quote a reference range for the other lipid results and says they should be assessed in terms of the overall risk to the patient.
Guidelines take the third view. They read LDL against a person's cardiovascular risk, not against a population range:
NICE (NG238). For people who already have cardiovascular disease and take lipid-lowering treatment, the goal is LDL cholesterol of 2.0 mmol/L or less, or non-HDL cholesterol of 2.6 mmol/L or less. For people without it who take a statin, NICE aims for a reduction of more than 40% in non-HDL cholesterol.
ESC/EAS (2019). Goals for people grouped by risk category: below 3.0 mmol/L (116 mg/dL) at low risk, below 2.6 mmol/L (100 mg/dL) at moderate risk, below 1.8 mmol/L (70 mg/dL) at high risk and below 1.4 mmol/L (55 mg/dL) at very high risk, the last two together with a reduction of at least 50% from baseline.
Risk category is a clinical judgement about the whole person, so the same LDL can be on goal for one person and far from it for another. That is the gap from the opening: 2.6 mmol/L is inside the Sussex range and above the NICE goal for people with cardiovascular disease on lipid-lowering treatment.
Why can LDL be high?
Inherited. NICE guidance on familial hypercholesterolaemia (CG71) says to suspect it in adults with total cholesterol above 7.5 mmol/L, or with a personal or family history of coronary heart disease before 60. NG238 asks for specialist assessment when total cholesterol is above 9.0 mmol/L or non-HDL cholesterol above 7.5 mmol/L, even without such a family history.
Secondary to another condition. NICE lists excess alcohol intake, uncontrolled diabetes, hypothyroidism, liver disease and nephrotic syndrome as common secondary causes to exclude. Our explainer on TSH covers the thyroid test that is part of that check.
Why can the result vary?
A calculated LDL carries the error of three measurements. The ESC/EAS guideline asks for calculated LDL to be interpreted with caution in people with diabetes, the metabolic syndrome or high triglycerides. CG71 asks for two LDL measurements before a diagnosis of familial hypercholesterolaemia is confirmed, because biological and analytical variability occurs.
High triglycerides change the next step. NICE suggests repeating the triglyceride test fasting, after 5 days but within 2 weeks, when it is between 10 and 20 mmol/L, and urgent specialist review above 20 mmol/L when alcohol or poor glucose control is not the cause.
What does a doctor usually check next?
The whole profile and a risk estimate. NICE asks for total and HDL cholesterol to estimate cardiovascular risk, and uses clinical findings, the full profile and family history, not strict cut-offs alone, to judge a familial lipid disorder.
Secondary causes. Before lipid-lowering treatment, NICE lists baseline tests: the full lipid profile, diabetes status, kidney function, liver enzymes, and TSH in people with thyroid symptoms.
Familial hypercholesterolaemia. When it is suspected, NICE describes clinical criteria (Simon Broome or the Dutch Lipid Clinic Network score) and referral to a specialist service for DNA testing.
What does this number not mean?
One LDL result is not a diagnosis of anything. Familial hypercholesterolaemia, for example, needs two measurements and clinical criteria, and may lead to DNA testing.
A value inside the printed range does not mean low cardiovascular risk, and a value above it does not by itself mean high risk.
It is not a reason to start, stop or change any medicine, supplement or diet on your own.
What to do with the number
Bring the whole lipid profile to your doctor: LDL, non-HDL cholesterol, HDL, triglycerides, and whether the sample was fasting. Mention heart attack, stroke or other cardiovascular disease, diabetes, kidney or thyroid disease, blood pressure, smoking, and any relative with very high cholesterol or early heart disease. Keep earlier results, because LDL is read as a series. You can follow LDL over time in your Lonevi health map. Our article on LDL cholesterol targets and how LDL is lowered goes further into goals, and the one on cholesterol, ApoB and longevity explains the particle count behind LDL.
Sources
National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238). 2023. nice.org.uk/guidance/ng238
National Institute for Health and Care Excellence. Familial hypercholesterolaemia: identification and management (CG71). 2008, updated 2019. nice.org.uk/guidance/cg71
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–188. PMID 31504418
University Hospitals Sussex Pathology. Lipid profile. 2026. pathology.uhsussex.nhs.uk
University Hospitals of North Midlands Pathology. LDL cholesterol. uhnm.nhs.uk
Gloucestershire Hospitals Pathology. Lipids (cholesterol, triglycerides, HDL, LDL). gloshospitals.nhs.uk
Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.
Read next
ExplainerBiomarkersVitamin D blood test: why the same number gets different labels
The bands on a vitamin D report come from expert judgements, not a population range, and SACN, NHS laboratories, the US Institute of Medicine and the Endocrine Society draw them differently. What moves the result and when testing helps.
ExplainerBiomarkersCreatinine and eGFR: why one low result is checked again
eGFR is calculated from creatinine, age and sex, and this page uses the race-free CKD-EPI 2021 equation. Where the KDIGO categories come from, what can shift creatinine, and why chronic kidney disease needs a change lasting more than 3 months.
ExplainerBiomarkersCRP blood test: one protein, two scales that read it differently
Routine CRP looks for infection and inflammation, high-sensitivity CRP for heart risk, and their cut-offs differ. How fast CRP rises and falls, what raises the baseline, and what doctors do with a single high value.
